
|Articles|December 1, 2002
- Applied Clinical Trials-12-01-2002
DHHS, FDA, NIH Locator
A former White House advisor on health policy, Mark McClellan, is FDA's new commissioner.
Advertisement
Articles in this issue
over 23 years ago
Education and Training Directoryover 23 years ago
Glossary of Clinical Research Terminologyover 23 years ago
Subject Recruitmentover 23 years ago
European Regulatory Agenciesover 23 years ago
Cross-over Trials in Clinical Researchover 23 years ago
Directory of Professional Societies and Associationsover 23 years ago
Glossary of Acronyms, Abbreviations, and InitialsAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced
2
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
3
Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV
4
Survey Finds US Biotechs Prefer Domestic First-in-Human Trials but FDA Hurdles Are Pushing Them Abroad
5



